rs200253809
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004646.4(NPHS1):c.2072-6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000302 in 1,613,586 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004646.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHS1 | NM_004646.4 | c.2072-6C>T | splice_region_variant, intron_variant | ENST00000378910.10 | NP_004637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.2072-6C>T | splice_region_variant, intron_variant | 1 | NM_004646.4 | ENSP00000368190.4 | ||||
NPHS1 | ENST00000585400.1 | n.254-6C>T | splice_region_variant, intron_variant | 1 | ||||||
NPHS1 | ENST00000353632.6 | c.2072-6C>T | splice_region_variant, intron_variant | 5 | ENSP00000343634.5 |
Frequencies
GnomAD3 genomes AF: 0.00165 AC: 251AN: 152260Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000426 AC: 106AN: 249014Hom.: 0 AF XY: 0.000333 AC XY: 45AN XY: 135188
GnomAD4 exome AF: 0.000162 AC: 236AN: 1461208Hom.: 1 Cov.: 31 AF XY: 0.000120 AC XY: 87AN XY: 726920
GnomAD4 genome AF: 0.00165 AC: 251AN: 152378Hom.: 2 Cov.: 32 AF XY: 0.00142 AC XY: 106AN XY: 74514
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 23, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Finnish congenital nephrotic syndrome Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 07, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at